A Q&A with Julia Vogel, a researcher fighting long COVID and searching for relief
Scripps Research computational biologist Julia Moore Vogel recently moved back to upstate New York to get help from family members with her severe fatigue caused by long COVID, a condition she has ...
News-Medical.Net14h
New research reveals potential path forward for glioblastoma treatment
Glioblastoma has remained one of the toughest cancers to treat, resisting even the latest advances in immunotherapy.
MyChesCo on MSN21h
Faeth Therapeutics and GOG Foundation Launch Pioneering Phase 2 Trial for Advanced Endometrial Cancer
AUSTIN, TX & PHILADELPHIA, PA — Faeth Therapeutics and The GOG Foundation, Inc. have announced a significant milestone in the ...
Healio22h
Filgotinib well-tolerated, efficacious for up to 8 years in rheumatoid arthritis
Filgotinib, a Janus Kinase 1 inhibitor, remains well-tolerated for up to 8 years with consistent efficacy in patients with ...
Nature3d
Clinical trials articles from across Nature Portfolio
Bilen et al. perform a phase 2 single-arm clinical trial of neoadjuvant cabozantinib in patients with locally advanced nonmetastatic clear cell renal cell carcinoma, assess efficacy and find ...
CURE13d
Checkpoint Inhibitor Therapy and ISRT Maintains Outcomes in Younger Patients With cHL
Replacing transplant and chemo with CI-based therapy and ISRT maintains survival, reduces side effects in younger patients ...
dvm36015d
Clinical history and patient selection for diet trials
However, as Sheinberg explained, not all “itchy” patients should go on diet trials, and a detailed clinical history could help determine if the patient is a suitable candidate for this test. Among ...
Monthly Prescribing Reference19d
One in 6 Patients in Phase 2 Cancer Trials Receive Drug That Is Eventually Approved
The proportion increases when considering off-label use but drops when considering drugs with substantial clinical benefit. HealthDay News — One in 6 patients in phase 2 clinical cancer trials ...
healthday19d
One in Six Patients in Phase 2 Cancer Trials Receive Drug When Eventually Approved
WEDNESDAY, Feb. 26, 2025 (HealthDay News) -- One in six patients in phase 2 clinical cancer trials receives treatments that are eventually approved, according to a study published online Feb. 25 in ...
FierceBiotech19d
Health tech firm partners with UK medical recordkeeper to match patients with clinical trials
Clinical trial matchmaker myTomorrows has struck up a partnership with personal health recordkeeper Patients Know Best (PKB) so that U.K. participants can search for possible trials to join.
UCL20d
Patient and Public Involvement
This course is a practical, interactive workshop for those working in clinical trials who already or wish to actively involve patients or the public in their trials. It offers participants the ...
GitHub20d
clinical-trial-management-system
LibreClinica is the community driven successor of OpenClinica. It is an open source clinical trial software for Electronic Data Capture (EDC) Clinical Data Management (CDM).